Plasma Shield wins funding for trials of air purifier
23 Aug 2021
Medical technology startup Plasma Shield has secured funding for trials of its innovative air purification technology, which could be used to stop the spread of superbugs such as COVID-19.
A $550,000 state government contribution will be matched with private investment to move ahead with trials of the Keswick company’s system in medical clinics.
The patented system uses a process of water electrolysis and non-thermal plasma – a cool gas renowned for high levels of air decontamination – to kill off harmful bacteria and viruses.